Area of research
Molecular Biology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Protein Kinase Regulation and GTPase Signaling, CRISPR and Genetic Engineering, Cardiac electrophysiology and arrhythmias, and Phosphodiesterase function and regulation.
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+
CaMKII as a Therapeutic Target in Cardiovascular Disease
Excessive <i>O</i> -GlcNAcylation Causes Heart Failure and Sudden Death
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy